Gwendolyn P. Quinn, PhD, on Sexual Health in AYA Cancer Survivors

Video

“As the number of AYA survivors continues to grow, there is a pressing need for targeted information, education, and intervention around sexual health, intimate relationships, and body image,” the Children’s Oncology Group (COG) AYA Oncology Discipline Committee wrote in a review.

A review from the Children’s Oncology Group (COG) AYA Oncology Discipline Committee, published in CA: A Cancer Journal for Clinicians, suggested that interventions to support sexual health are necessary for adolescent and young adult (AYA) cancer survivors.

The committee’s Sexual Health Task Force conducted a review of articles specifically focused on sexual dysfunction, sexual desire, satisfaction, body image, and romantic relationships among posttreatment AYA cancer survivors who were diagnosed with cancer in childhood, adolescence, or young adulthood. Ultimately, the review suggested that collaborations between the COG and adult-focused cooperative groups associated with the National Cancer Institute’s National Clinical Trials Network (NCTN) are necessary to enhance assessment of sexual dysfunction and test interventions to improve sexual health among this patient population.

“As the number of AYA survivors continues to grow, there is a pressing need for targeted information, education, and intervention around sexual health, intimate relationships, and body image,” the authors of the review wrote.

“Building on the results of this review, the COG is poised to develop a prospective study of AYA sexual health through the inclusion of key measures within NCTN-wide survivorship studies and concomitantly contribute to ongoing education for providers and patients.”

In an interview with CancerNetwork®, Gwendolyn P. Quinn, PhD, professor in the Departments of Obstetrics and Gynecology as well as Population Health at NYU Grossman School of Medicine, discussed what will be necessary to address the issues identified in the review and improve young cancer survivors’ quality of life.

Reference:

Cherven B, Sampson A, Bober SL, et al. Sexual health among adolescent and young adult cancer survivors: A scoping review from the Children’s Oncology Group Adolescent and Young Adult Oncology Discipline Committee. CA Cancer J Clin. Published December 7, 2020. doi: 10.3322/caac.21655

Related Videos
It takes a team of physicians from multidisciplinary backgrounds to best manage patients with contralateral breast cancer, according to a Mayo Clinic Expert.
The presence of several risk factors—such as age, race and mutation status—for contralateral breast cancer must be considered when making treatment decisions, according to an expert from the Mayo Clinic.
Recent study findings related to risk factors for developing contralateral breast cancer may better influence treatment decisions between patients and physicians, according to a Mayo Clinic expert.
An expert from the Mayo Clinic discusses findings from a population-based study concerning germline genetic mutations as risk factors of contralateral breast cancer.
Thus far, findings from 2 trials show that treatment with bipolar androgen therapy is associated with several benefits in patients with castration-resistant prostate cancer, according to an expert from Sidney Kimmel Comprehensive Cancer Center.
An expert from the Mayo Clinic explains why he and his colleagues are researching risk factors for contralateral breast cancer in carriers of moderate-risk genes such as ATM, CHEK2, and PALB2.
Investigators have observed that treatment with bipolar androgen therapy has suppressed at least one oncogene in patients with castration-resistant prostate cancer who derived a response to therapy.
Despite the observed disease-free survival benefit associated with pembrolizumab in high-risk kidney cancer after surgery, the European Association of Urology guidelines maintain a weak recommendation for its use.
Don Dizon, MD, FACP, FASCO, describes the importance of establishing a gender-affirming environment for patients with cancer.
Related Content